Category 6 - PATHOLOGY SERVICES
73332 - Additional Information
Item Start Date:
01-May-2012
Description Updated:
01-Dec-2012
Schedule Fee Updated:
01-Jan-2013
Group
P7 - Genetics
An in situ hybridization (ISH) test of tumour tissue from a patient with breast cancer requested by, or on the advice of, a specialist or consultant physician who manages the treatment of the patient to determine if the requirements relating to human epidermal growth factor receptor 2 (HER2) gene amplification for access to trastuzumab under the Pharmaceutical Benefits Scheme (PBS) or the Herceptin Program are fulfilled.
Fee: $315.40 Benefit: 75% = $236.55 85% = $268.10
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change